Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Repositioning approved drugs for the treatment of problematic cancers using a screening approach

Table 1

Cytotoxicity (expressed as IC50 values) of selected PCL hits in A549 and PANC-1 cells in comparison with platinum-based drugs commonly used in treatment regimens for both lung and pancreatic cancers.

Table 1